Trial intelligence / Profile preview

Carbetocin vs Oxytocin for Placental Delivery in 2nd Trimester Interruption

NCT01827124Phase 4Unknown

Start
Apr 2013
Primary completion
Nov 2013
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of carbetocin in retained placenta. Status: unknown.

02

Drugs

carbetocin
03

Conditions

retained placenta

Beyond the preview

Go deeper on NCT01827124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01827124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call